David Goldberg
Overview
Explore the profile of David Goldberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
301
Citations
5654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Potluri V, Goldberg D, Zhang S, Schaubel D, Molnar M, Forbes R, et al.
Transpl Infect Dis
. 2025 Mar;
:e70011.
PMID: 40047349
Background: Several studies have suggested an increased risk of cytomegalovirus (CMV) viremia among Hepatitis C virus (HCV)-uninfected recipients of kidney transplants from HCV-RNA+ deceased donors (HCV D+/R-), but these studies...
2.
Goldberg D, Ishwaran H, Potluri V, Harhay M, Vail E, Abt P, et al.
Liver Transpl
. 2025 Jan;
PMID: 39882963
In the field of organ transplantation, the accurate assessment of donor organ quality is necessary for efficient organ allocation and informed consent for recipients. A common approach to organ quality...
3.
4.
Blandon C, Goldberg D
Transplantation
. 2024 Dec;
109(1):106-107.
PMID: 39656136
No abstract available.
5.
Kania B, Lolis M, Goldberg D
J Cosmet Dermatol
. 2024 Nov;
24(2):e16669.
PMID: 39533523
Background: Botulinum toxin A (BTX-A) is a widely utilized protein derived from the bacterium Clostridium botulinum, known for its effectiveness in treating various medical conditions involving muscle spasticity, involuntary muscle...
6.
Finotti M, Wall A, DAlessandro A, Schwartz G, Sonnenday C, Goldberg D, et al.
Hepatobiliary Surg Nutr
. 2024 Nov;
13(5):824-836.
PMID: 39507724
Despite a significant increase in utilization over the past decade, the number of donation after circulatory death (DCD) organs that are procured and transplanted in the United States (US) remains...
7.
Goldberg D, Reese P, Kaplan D, Zarnegarnia Y, Gaddipati N, Gaddipati S, et al.
Hepatol Commun
. 2024 Nov;
8(11).
PMID: 39495142
Background: Prognosticating survival among patients with HCC and cirrhosis must account for both the tumor burden/stage, as well as the severity of the underlying liver disease. Although there are many...
8.
Goldberg D, Wilder J, Terrault N
Nat Rev Gastroenterol Hepatol
. 2024 Nov;
22(2):98-111.
PMID: 39482363
Morbidity and mortality from cirrhosis are substantial and increasing. Health disparities in cirrhosis and liver transplantation are reflective of inequities along the entire spectrum of chronic liver disease care, from...
9.
Gold M, Biesman B, Cohen J, Day D, Goldberg D, Guenin S, et al.
J Cosmet Dermatol
. 2024 Sep;
23 Suppl 4:1-9.
PMID: 39291701
Introduction: Real-world experience using an allograft adipose matrix (AAM) (Renuva) is presented as a series of seven cases demonstrating successful use of the matrix by nine expert cosmetic physicians across...
10.
Rosenstengle C, Serper M, Asrani S, Bittermann T, Du J, Ma T, et al.
J Hepatol
. 2024 Aug;
82(2):268-276.
PMID: 39181212
Background & Aims: Kidney dysfunction is a major determinant of prognosis in patients with decompensated cirrhosis awaiting transplantation. We hypothesized that for identical model for end-stage liver disease (MELD) scores...